(Q53902929)

22 May 2018

title

Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study. (English)

1 reference

22 May 2018

1 reference

2

1 reference

22 May 2018

John-Paul Bogers

8

1 reference

22 May 2018

author name string

Shaira Sahebali

1

1 reference

22 May 2018

Gaëlle A V Boulet

3

1 reference

22 May 2018

Marc Arbyn

4

1 reference

22 May 2018

Liliane M Moeneclaey

5

1 reference

22 May 2018

Annie J Vereecken

6

1 reference

22 May 2018

Eric A Van Marck

7

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 March 2006

1 reference

22 May 2018

International Journal of Cancer

published in

1 reference

22 May 2018

volume

118

1 reference

22 May 2018

issue

5

1 reference

22 May 2018

page(s)

1254-1260

1 reference

22 May 2018

Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy

cites work

1 reference

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

The 2001 Bethesda System: terminology for reporting results of cervical cytology

21 January 2018

1 reference

2001 Consensus Guidelines for the management of women with cervical cytological abnormalities

21 January 2018

1 reference

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

21 January 2018

1 reference

A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions

21 January 2018

1 reference

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

21 January 2018

1 reference

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

Translational approaches to improving cervical screening

21 January 2018

1 reference

Ki67 protein: the immaculate deception?

21 January 2018

1 reference

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections

21 January 2018

1 reference

Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool?

21 January 2018

1 reference

P16INK4a as an adjunct marker in liquid-based cervical cytology.

21 January 2018

1 reference

Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women.

21 January 2018

1 reference

Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia

21 January 2018

1 reference

Cervical cancer screening in Belgium.

21 January 2018

1 reference

Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.21489

1 reference

22 May 2018

1 reference

22 May 2018